Serum IL‐6 and MCP‐1 concentrations in dogs with lymphoma before and after doxorubicin treatment as a potential marker of cellular senescence
Abstract Background Chemotherapy can induce cellular senescence and a secretory phenotype characterized by an increased expression of inflammatory cytokines, such as IL‐6 and MCP‐1. Increased IL‐6 and MCP‐1 serum concentrations have been documented in dogs with lymphoma, but no studies have evaluate...
Main Authors: | Brittany L. Evans, Joelle M. Fenger, Greg Ballash, Megan Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Veterinary Medicine and Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/vms3.633 |
Similar Items
-
Tolerability and Effects of 2-Aminoethyl Dihydrogen Phosphate in Dogs With Mast Cell Tumors
by: Eric Vieira Januário, et al.
Published: (2022-07-01) -
Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma
by: Sami Al-Nadaf, et al.
Published: (2018-11-01) -
Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
by: Kristen M. Weishaar, et al.
Published: (2022-01-01) -
Successful Treatment of Central Nervous System Lymphoma with Combination Therapy of Nimustine and Prednisolone in Two Dogs
by: Yuko Mizutani, et al.
Published: (2023-08-01) -
Evaluation of Health Related Quality of Life in Dogs Treated with Chemotherapy for Lymphoma
by: Atanaskova Petrov Elena, et al.
Published: (2023-06-01)